CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together” Nov 16, 2021
COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021 Nov 9, 2021
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder Nov 3, 2021
Numinus Offering Ketamine Assisted Psychotherapy At Two Clinics in Canada, Psychedelic Neurology Centre On The Horizon Oct 8, 2021
Mydecine Patent Filing Links Psychedelic Therapeutics & PTSD: Psychedelic Stock Investing Oct 7, 2021
Great News for Psychedelics Companies – Journey Clinical Raised $3M Funding For Mental Health Treatment Sep 30, 2021